Page 108 - 南京医科大学自然版
P. 108

第45卷第7期
               ·1006 ·                           南 京    医 科 大 学 学         报                        2025年7月


              高、30 d预后更差。                                            LIU Z Y,CHEN Y B,JI J R,et al. 2022 National bacterial
                  利益冲突声明:                                            monitoring report:Gram ⁃ negative bacteria[J]. Chinese
                  所有作者声明不存在利益冲突。                                     Journal of Clinical Infectious Diseases,2024,17(1):42-
                  Conflict of Interests:                             57
                  There is no conflict of interests.            [7] LI Y T,GUO J X,YANG H M,et al. Comparison of
                  作者贡献声明:                                            culture ⁃ negative and culture ⁃ positive sepsis or septic
                  李天时负责数据收集、整理、统计分析、初稿撰写;朱轶                          shock:a systematic review and meta ⁃ analysis[J]. Crit
              负责实验设计、统计分析、作图、写作审阅;张忠满负责写作                            Care,2021,25(1):167
              审阅和编辑;陈家慧、尤晓冬负责数据收集、整理;李伟负责                       [8] YIN M,TAMBYAH P A,PERENCEVICH E N. Infection,
              实验设计、研究指导、写作审阅和编辑;陈旭锋负责研究指                             antibiotics,and patient outcomes in the intensive care
              导、经费支持;黄培培负责实验设计、研究指导、写作审阅和                            unit[J]. JAMA,2020,323(15):1451-1452
              编辑。                                               [9] THADEN J T,CANTRELL S,DAGHER M,et al. Associ⁃
                  Author’s Contributions:                            ation of follow⁃up blood cultures with mortality in patients
                  LI Tianshi was responsible for data collection,collation,  with gram ⁃ negative bloodstream infections:a systematic

              statistical analysis,and first draft writing;ZHU Yi was responsible  review and meta⁃analysis[J]. JAMA Netw Open,2022,5
              for research,statistical analysis,drawing and writing review;  (9):e2232576
              ZHANG Zhongman was responsible for writing review and  [10] NIEDERMAN M S,BARON R M,BOUADMA L,et al.
                                                                     Initial antimicrobial management of sepsis[J]. Crit Care,
              editing;CHEN Jiahui and YOU Xiaodong were responsible for
              data collection and collation ;LI Wei was responsible for  2021,25(1):307
              research design,research guidance,writing review and editing;  [11]CHENG M P,STENSTROM R,PAQUETTE K,et al.
                                                                     Blood culture results before and after antimicrobial
              CHEN Xufeng was responsible for research guidance and finan⁃
              cial support;HUANG Peipei was responsible for research,  administration in patients with severe manifestations of
                                                                     sepsis:a diagnostic study[J]. Ann Intern Med,2019,171
              guidance,writing review and editing.
                                                                    (8):547-554
             [参考文献]
                                                                [12]EVANS L,RHODES A,ALHAZZANI W,et al. Surviving
             [1] YOUNG G B,BOLTON C F,AUSTIN T W,et al. The          sepsis campaign:international guidelines for management
                   encephalopathy associated with septic illness[J]. Clin  of sepsis and septic shock 2021[J]. Intensive Care Med,
                   Invest Med,1990,13(6):297-304                     2021,47(11):1181-1247
             [2] SONNEVILLE R,BENGHANEM S,JEANTIN L,et al.      [13]MUNFORD R S. Severe sepsis and septic shock:the role
                   The spectrum of sepsis ⁃ associated encephalopathy:a  of Gram⁃negative bacteremia[J]. Annu Rev Pathol,2006,
                   clinical perspective[J]. Crit Care,2023,27(1):386  1:467-496
             [3] MAZERAUD A,RIGHY C,BOUCHEREAU E,et al. Septic⁃  [14]OHNUMA T,CHIHARA S,COSTIN B,et al. Epidemiology,
                   associated encephalopathy:a comprehensive review[J].  resistance profiles,and outcomes of bloodstream infec⁃
                   Neurotherapeutics,2020,17(2):392-403              tions in community⁃onset sepsis in the United States[J].
             [4] 王    娜,张珍珍,刘一瑾,等. 医院血流感染革兰阴性菌                       Crit Care Med,2023,51(9):1148-1158
                   分布及耐药性变迁[J]. 中华临床感染病杂志,2020,13               [15]RODRÍGUEZ⁃NÚÑEZ O,AGÜERO D L,MORATA L,et
                  (3):205-209                                        al. Antibiotic ⁃ resistant microorganisms in patients with
                   WANG N,ZHANG Z Z,LIU Y J,et al. Distribution and  bloodstream infection of intraabdominal origin :risk
                   drug ⁃ resistance changes of Gram ⁃ negative bacteria[J].  factors and impact on mortality[J]. Infection,2021,49
                   Chinese Journal of Clinical Infectious Diseases,2020,13  (4):693-702
                  (3):205-209                                   [16] VINCENT J L,SAKR Y,SINGER M,et al. Prevalence
             [5] SINGER M,DEUTSCHMAN C S,SEYMOUR C W,et al.          and outcomes of infection among patients in intensive
                   The third international consensus definitions for sepsis  care units in 2017[J]. JAMA,2020,323(15):1478-
                   and septic shock(sepsis⁃3)[J]. JAMA,2016,315(8):  1487
                   801-810                                      [17]李晓华,付      裕,曹    贤,等. 2017 年—2022 年某院住
             [6] 刘志盈,陈云波,嵇金如,等. 2022 年全国血流感染细                        院患者血流感染病原菌分布及耐药分析[J]. 国外医药
                   菌耐药监测报告:革兰阴性菌[J]. 中华临床感染病杂                       (抗生素分册),2024,45(5):312-318

                   志,2024,17(1):42-57                                                         (下转第1034页)
   103   104   105   106   107   108   109   110   111   112   113